Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. spinitcompanion

spinitCompanion

A point of care device to provide real-time blood analysis for chronic diseases.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 spinitCompanion project word cloud

Explore the words cloud of the spinitCompanion project. It provides you a very rough idea of what is the project "spinitCompanion" about.

lab    poc    disposable    competitiveness    market    multiple    people    central    blood    device    setting    instrument    quantifies    panel    performing    clinical    accuracy    drop    diagnostic    fits    markets    recurrently    accurate    reg    platform    social    diseases    scenario    healthcare    sme    time    longer    treatment    minutes    public    reader    point    near    ivd    positive    compliance    cover    provides    regulation    correct    faster    urgent    reliance    significantly    innovative    smartphone    doctors    cheaper    patients    standard    health    patient    vitro    removing    ip    full    spinitcompanion    efficiency    care    healthy    biosurfit    responds    assays    analyser    tests    spinit    chronic    keeping    flagship    laboratories    waiting    tool    manufacturing    protected    cartridges    diagnosis    strategy    independent    sustainability    vision    times    productivity    plan    outlined    leverages    solution    active    patents    centralised    economic    commercialization    marketing    single   

Project "spinitCompanion" data sheet

The following table provides information about the project.

Coordinator		 BIOSURFIT SA 

Organization address
address: CENTRO EMPRESARIAL DE AVEIRO
city: AVEIRO
postcode: 3810 744
website: www.biosurfit.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Portugal [PT]
 Project website http://biosurfit.com/spinit-available-tests/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-12-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOSURFIT SA PT (AVEIRO) coordinator 50˙000.00

Map

 Project objective

biosurfit have developed an In Vitro Diagnostic (IVD) tool - the spinitCompanion - enabling the testing for a wide range of blood parameters that are needed for urgent and accurate diagnosis in order to deliver the correct treatment for chronic diseases. The solution comprises an analyser, a smartphone application and disposable cartridges to process a single drop of blood and provide doctors with real time results. biosurfit's user-friendly device allows for multiple panel blood assays - near or at the patient Point of Care (PoC) - with the use of one single platform. This solution is cheaper and significantly faster than performing such tests recurrently, as chronic conditions require, in a standard lab setting, Furthermore the technology provides a high level of accuracy (comparable to established central lab tests), and quantifies the presence of specific clinical parameters in less than 10 minutes. biosurfit’s solution responds to two main objectives outlined in the EU Health Strategy, which cover both relevant economic and social aspects: 1) Improve the sustainability and efficiency of social and healthcare system 2) Keeping people healthy and active for longer has a positive impact on productivity and competitiveness. The spinitCompanion fully fits with biosurfit’s overall strategy with an innovative product that leverages on the same flagship technology platform - spinit® reader - already on the market and now protected with 20 independent patents. biosurfit’s vision and main goal is to deliver blood analysis testing to the public, removing its reliance on centralised laboratories and long waiting times both for patients and doctors. In this scenario, the SME Instrument project will enable an important step in achieving EU regulation compliance and the development of a full manufacturing and commercialization plan, and strong IP/marketing strategy based on in-depth analysis of European markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SPINITCOMPANION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SPINITCOMPANION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More